U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07195929) titled 'Determination of Blomia Tropicalis Allergen Extract in Prick Test Units' on Sept. 19.
Brief Summary: The primary objective is to assess the concentration of Blomia tropicalis allergenic extract that induces a wheal of size equivalent to that produced by a 10 mg/mL histamine dihydrochloride solution, in order to be used as in-house reference preparation (IHRP).
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Allergy Pollen
Allergic Reactions
Allergic Skin Reaction
Intervention:
OTHER: Allergenic Extract
In each subject, a drop of each of the 3 concentrations of the allergenic extract, in addition to the pos...